Post-approval studies (Phase 4)Looking for participantsNCT06909214
What this trial is testing
Evaluate the Clinical Outcomes of Efgartigimod PH20 SC in Adults With New-onset Generalized Myasthenia Gravis (gMG)
Who this might be right for
New Onset Generalized Myasthenia Gravis (gMG)
argenx 30